osimertinib
astrazeneca
['lung', 'osimertinib', 'nsclc', 'sclc']
 the problem with the way the tweet is written is that it might prompt nsclc lung ca pts to think that 1 in 4 of them might be candidates for osimertinib... and that would certainly be wrong
Keeping an eye out for advances that will help my patients. Tweets my own; not medical advice. End #clinicaltrialgerrymandering